The Association between Kidney Function and the Severity of COVID-19 in Children

Dedi Rachmadi; Ahmedz Widiasta; Hadyana Sukandar; Nanan Sekarwana; Dany Hilmanto

doi:10.3889/oamjms.2022.9784

Authors

Dedi Rachmadi Department of Child Health, Division of Pediatric Nephrology, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Medical Genetic Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
Ahmedz Widiasta Department of Child Health, Division of Pediatric Nephrology, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia; Medical Genetic Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
Hadyana Sukandar Department of Public Health, Division of Epidemiology and Biostatistics, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
Nanan Sekarwana Department of Child Health, Division of Pediatric Nephrology, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia
Dany Hilmanto Department of Child Health, Division of Pediatric Nephrology, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9784

Keywords:

COVID-19, Kidney function, Disease severity, Children

Abstract

BACKGROUND: Kidney manifestations are life-threatening conditions, such as end-stage kidney disease, notably when caused by viral infections. The severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), is an emerging global health problem, potentially affecting all organs, including the kidney. Most reports on kidney manifestations were focused on the adult and elderly population but limited on children.

AIM: This study aims to analyze the association between kidney function and the severity of the disease of pediatric patients suffering from COVID-19.

METHODS: From March 2020 to March 2021, an observational analytic study was conducted in Hasan Sadikin General Hospital, Bandung, Indonesia. The demographic data, clinical signs, laboratory results, and notable kidney function were analyzed, and based on its clinical appearance the disease was classified as severe and non-severe. Subsequently, the Mann–Whitney test for nonparametric was used to analyze the collected data.

RESULTS: In this study, 40 COVID-19 children were selected as the subjects, and the median estimated glomerular filtration rate (eGFR) value in the severe group was discovered to be lower (88.2 mL/min/1.73 m2) compared to the non-severe (124.4 mL/min/1.73 m2), it was statistically significant (p = 0.041). There was no difference in hemoglobin and leukocyte values between the two groups (p > 0.05). Furthermore, the CRP and NLR results showed no difference between the groups (p > 0.05).

CONCLUSION: A severe SARS-CoV-2 infection correlates with kidney function, which was manifested by a lower median eGFR value in the severe compared to the non-severe group.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Hoffmann M, Weber KH, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https://doi.org/10.1016/j.cell.2020.02.052 PMid:32142651 DOI: https://doi.org/10.1016/j.cell.2020.02.052

Moghtaderi M. Continuous renal replacement therapy (CRRT) in patients with COVID-19 infection. J Pediatr Nephrol. 2020;8:1-14.

Na KR, Kim HR, Ham Y, Choi DE, Lee KW, Moon JY, et al. Acute kidney injury and kidney damage in COVID-19 patients. J Korean Med Sci. 2020;35:e257. https://doi.org/10.3346/jkms.2020.35.e257 DOI: https://doi.org/10.3346/jkms.2020.35.e257

Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J Microbiol Immunol Infect. 2021;54(2):159-163. https://doi.org/10.1016/j.jmii.2020.03.022 PMid:32265180 DOI: https://doi.org/10.1016/j.jmii.2020.03.022

Widiasta A, Sribudiani Y, Nugrahapraja H, Hilmanto D, Sekarwana N, Rachmadi D. Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy. Noncoding RNA Res. 2020;5(4):153-66. https://doi.org/10.1016/j.ncrna.2020.09.001 PMid:32923747 DOI: https://doi.org/10.1016/j.ncrna.2020.09.001

Liu Z, Huang XR, Chen HY, Fung E, Liu J, Lan HY. Deletion of angiotensin-converting enzyme-2 promotes hypertensive nephropathy by targeting smad7 for ubiquitin degradation. Hypertension. 2017;70(4):822-30. https://doi.org/10.1161/hypertensionaha.117.09600 PMid:28808068 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.117.09600

Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi MM. Is coronavirus disease 2019 (COVID-19) associated with renal involvement? A review of century infection. Jundishapur J Microb Kowsar. 2020;13(4):e102899. https://doi.org/10.5812/jjm.102899 DOI: https://doi.org/10.5812/jjm.102899

Stewart DJ, Hartley JC, Johnson M, Marks SD, Pré P, Stojanovic J. Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health. 2020;4(8):e28-9. https://doi.org/10.1016/s2352-4642(20)30178-4 PMid:32553126 DOI: https://doi.org/10.1016/S2352-4642(20)30178-4

Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339-48. https://doi.org/10.1007/s00134-020-06153-9 PMid:33804100 DOI: https://doi.org/10.1007/s00134-020-06153-9

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. Kidney Int. 2020;97(5):829-38. PMid:32247631 DOI: https://doi.org/10.1016/j.kint.2020.03.005

Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, et al. Acute kidney injury in COVID-19: Emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020;31(7):1380-3. https://doi.org/10.1681/asn.2020040419 PMid:32366514 DOI: https://doi.org/10.1681/ASN.2020040419

Nacif LS, Zanini LY, Waisberg DR, Pinheiro RS, Galvão F, Andraus W, et al. COVID-19 in solid organ transplantation patients: A systematic review. Clinics. (Sao Paulo). 2020;75:e1983. https://doi.org/10.6061/clinics/2020/e1983 PMid:32520225 DOI: https://doi.org/10.6061/clinics/2020/e1983

Yang X, Zhao H, Li Y, Zhang P. Angiotensin converting enzyme 2 in coronavirus disease (COVID-19): Evidence from bioinformatics analysis. Med Pharm. 2020;1:4. https://doi.org/10.20944/preprints202004.0466.v1 DOI: https://doi.org/10.20944/preprints202004.0466.v1

Yang D, Leibowitz JL. Since January 2020 Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company’s Public News and Information. Amsterdam, Netherlands: Elsevier; 2020.

Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5(5):580-5. https://doi.org/10.1016/j.ekir.2020.04.001 DOI: https://doi.org/10.1016/j.ekir.2020.04.001

Melo AK, Milby KM, Caparroz AL, Pinto AC Santos RR, Rocha AP, et al. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis. PLoS One. 2021;16(6):e0253894. https://doi.org/10.1371/journal.pone.0253894 PMid:34185801 DOI: https://doi.org/10.1371/journal.pone.0253894

Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, et al. Outcomes for patients with COVID-19 and acute kidney injury: A systematic review and meta-analysis. Kidney Int Rep. 2020;5(8):1149-60. https://doi.org/10.1016/j.ekir.2020.06.013 PMid:32775814 DOI: https://doi.org/10.1016/j.ekir.2020.06.013

Widiasta A, Wahyudi K, Sribudiani Y, Rachmadi D. The level of transforming growth factor beta as a possible predictor of cyclophosphamide response in children with steroid-resistant nephrotic syndrome. Bio Med. 2021;11(3):67-75. https://doi.org/10.37796/2211-8039.1205 DOI: https://doi.org/10.37796/2211-8039.1205

Li B, Zhang S, Zhang R, Chen X, Wang Y, Zhu C. Epidemiological and clinical characteristics of COVID-19 in children: A systematic review and meta-analysis. Front Pediatr. 2020;8:591132. https://doi.org/10.3389/fped.2020.591132 PMid:33224909 DOI: https://doi.org/10.3389/fped.2020.591132

Wang M, Xiong H, Chen H, Li Q, Ruan XZ. Renal injury by SARS-CoV-2 infection: A systematic review. Kidney Dis. 2021;7(2):100-10. https://doi.org/10.1159/000512683 PMid:33821207 DOI: https://doi.org/10.1159/000512683

Blandin AF, Renner G, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M. ß1 Integrins as therapeutic targets to disrupt hallmarks of cancer. Front Pharmacol. 2015;6:279. https://doi.org/10.3389/fphar.2015.00279 PMid:26635609 DOI: https://doi.org/10.3389/fphar.2015.00279

Li Y, Wang H, Wang F, Du H, Liu X, Chen P, et al. Comparison of hospitalized patients with pneumonia caused by COVID-19 and influenza a in children under 5 years. Int J Infect Dis. 2020;98:80-3. https://doi.org/10.1016/j.ijid.2020.06.026 PMid:32535301 DOI: https://doi.org/10.1016/j.ijid.2020.06.026

Ren GL, Wang XF, Xu J, Li J, Meng Q, Xie GQ, et al. Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: A retrospective multi-center cohort study during COVID-19 outbreak. Mil Med Res. 2021;8(1):1-14. PMid:33593415 DOI: https://doi.org/10.1186/s40779-021-00306-7

Börnert P, Norris DG. A half-century of innovation in technology-preparing MRI for the 21st century. Br J Radiol. 2020;93:20200113. https://doi.org/10.1259/bjr.20200113 PMid:32496816 DOI: https://doi.org/10.1259/bjr.20200113

Palabiyik F, Kokurcan SO, Hatipoglu N, Cebeci SO, Inci E. Imaging of COVID-19 pneumonia in children. Br J Radiol. 2020;93(113):20200647. https://doi.org/10.1259/bjr.20200647 PMid:32730110 DOI: https://doi.org/10.1259/bjr.20200647

Lin L, Fu G, Chen S, Tao J, Qian A, Yang Y, et al. CT manifestations of coronavirus disease (COVID-19) pneumonia and influenza virus pneumonia: A comparative study. Am J Roentgenol. 2021;216(1):71-9. https://doi.org/10.2214/ajr.20.23304 PMid:32755175 DOI: https://doi.org/10.2214/AJR.20.23304

Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front public Health. 2020;8:152. https://doi.org/10.3389/fpubh.2020.00152 PMid:32411652 DOI: https://doi.org/10.3389/fpubh.2020.00152

Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. https://doi.org/10.1186/s13293-020-00304-9 PMid:32450906 DOI: https://doi.org/10.1186/s13293-020-00304-9

Bao H, Gao F, Xie G, Liu Z. 2. Cell Physiol Biochem. 201 Angiotensin-converting enzyme 2 inhibits apoptosis of pulmonary endothelial cells during acute lung injury through suppressing MiR-4265;35(6):2203-12. https://doi.org/10.1159/000430393 PMid:25896672 DOI: https://doi.org/10.1159/000374025

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875-9. https://doi.org/10.1038/nm1267 PMid:16007097 DOI: https://doi.org/10.1038/nm1267

Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis. 2020;20(6):689-96. https://doi.org/10.1016/s1473-3099(20)30198-5 DOI: https://doi.org/10.1016/S1473-3099(20)30198-5

Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: Sepsis, HIT, and antiphospholipid syndrome. Hematol Am Soc Hematol Educ Program. 2003;1:497-519. https://doi.org/10.1182/asheducation-2003.1.497 DOI: https://doi.org/10.1182/asheducation-2003.1.497